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Abstract  
Red meat is considered a risk factor for colorectal cancer (CRC). Heme is considered to 
promote colonic hyperproliferation and cell damage.  Resistant starch (RS) is a food that 
ferments in the colon with studies demonstrating protective effects against CRC. Utilising the 
western diet model of spontaneous CRC we determined if feeding heme (as hemin chloride) 
equivalent to a high red meat diet would increase colonic DNA adducts and CRC and 
whether RS could abrogate such effects. Four groups of mice: Control, Heme, RS and 
Heme+ RS were fed diets for 1 or 18 months. Colons were analysed for apoptosis, 
proliferation, DNA adducts ‘8-hydroxy-2 deoxyguanosine’ (8-oxo) and ‘O6-Methyl-2-
deoxyguanosine’ (O6MeG) and neoplasms. In the short term, heme increased cell 
proliferation (p<0.05). Changes from 1 to 18 months showed increased cell proliferation 
(p<0.01) and 8-oxo adducts (p<0.05) in all groups, but only heme-fed mice showed reduced 
apoptosis (p<0.01) and increased O6MeG adducts (p<0.01). The incidence of colon 
neoplasms was not different between any interventions. We identified heme to increase 
proliferation in the short term, inhibit apoptosis over the long term and increase O6MeG 
adducts in the colon over time although these changes did not affect colonic neoplasms 
within this mouse model. 
 
Introduction  
 Colorectal cancer (CRC) is a major burden on public health in developed countries 
with high incidence and mortality rates globally [1]. Although the development of CRC can be 
attributed partly to familial inherent mutations, a major driving force behind CRC formation is 
related to lifestyle factors, in particular dietary choices [2]. The consumption of red meat has 
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been identified as a risk factor for developing CRC by the World Cancer Research Fund [3]. 
However, the mechanisms by which red meat might initiate oncogenesis in the colon are not 
clearly known.  
 Increased DNA alkyl adducts in the colon via excess endogenous N-nitrosation is one 
mechanism that is thought to play a role in colorectal oncogenesis, although little is known 
about DNA adduct formation in the colon in response to red meat consumption [4] [5]. Our 
recent studies have shown that red meat can enhance the production of the pro-mutagenic 
adduct O6-Methyl-2-deoxyguanosine (O6MeG) after feeding of high red meat diets to mice, 
without chemical carcinogenic intervention [4]. The O6MeG adduct is a known mutagenic 
lesion in both animals and humans resulting from exposure to alkylating agents and is 
repaired by the enzyme O6-methylguanine-DNA methyltransferase. Persistence of 
unrepaired O6MeG adduct changes the chemical bonds in the DNA backbone and thus the 
DNA polymerase reads the G as an A after one round of replication. If this mismatch is not 
repaired, further changes in the DNA backbone lead to the polymerase incorporating a T 
instead of a C, therefore a GC:AT transition mutation arises following a second round of 
replication [6]. This transition mutation has been identified in several genes including the K-
ras gene, where mutation of this gene is a known mechanism of human oncogene activation 
in CRC [6].   
 The DNA oxidative adduct 8-hydroxy-2 deoxyguanosine (8-oxo) has been implicated 
in development of cancer for several years [7]. 8-oxo is a pro-mutagenic adduct that if not 
repaired or removed from the cell can incorporate base insertions into the DNA, with G  T 
tranversions being the most abundant [8]. The major repair pathway for this DNA adduct is 
via base excision repair, with the DNA glycosylase enzyme OGG1 having an affinity for 
excising the 8-oxo adduct from the DNA [9]. Patients with CRC and inflammatory bowel 
disease present with higher levels of 8-oxo measured in plasma [10, 11] and CRC patients 
show higher levels of 8-oxo DNA adducts measured in colon tissue compared to patients 
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without CRC [12, 13]. 8-oxo adducts are clearly linked with carcinogenesis although the 
significance of the 8-oxo adduct and consumption of red meat or heme in CRC has not been 
studied extensively.   
 Heme iron in red meat has been implicated in development of CRC in humans [14]. 
There are many different proteins regulating heme iron absorption in the small intestine and 
although it is readily bio-available there is a limitation to its absorption, therefore it is easily 
able to reach the colon [15, 16]. Various animal studies have shown that diets with heme 
concentrations above average human consumption levels (0.25-1.5µmol/g) [17] contribute to 
cell toxicity, hyper-proliferation, reduced apoptosis and increased rates of CRC [16-22]. A 
diet incorporating low levels of heme (at 0.25µmol/g) has shown a reduction in total number 
of aberrant crypt foci (ACF) per colon, although the ACF size was larger with heme diets 
compared to a control diet [18]. The intake of heme from a 30% red meat diet as beef would 
equate to an average concentration of 0.14µmol/g [19], indicating that 0.25µmol/g of heme 
more closely resembles that of a high red meat intake in humans. Besides causing damage 
to the colon cells directly, heme-iron from red meat also triggers the formation of potentially 
damaging DNA alkylating N-nitroso compounds (NOC) either via increasing bacterial nitrate 
reductase activity or via reacting with nitrite or nitric oxide in the lumen [20]. In humans, 
consumption of high levels of red meat has been directly related to increased alkyl adducts in 
the colon, and this was correlated to increased faecal NOC output [21]. There are strong 
indications that heme contributes to development of CRC. However to date, there have been 
no rodent studies conducted examining a heme diet at levels relevant to human consumption 
to identify its long term effects on colorectal cancer risk without utilising chemical 
carcinogens to induce cancer to date utilising solely,.  However, to directly assess the 
carcinogenic potential of dietary heme without utilising chemical carcinogens or other 
spontaneous models huge numbers of animals per group are required to detect any possible 
effect on carcinogenicity. 
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 On the opposing side, a dietary component that has been implicated in protection 
against CRC is resistant starch (RS), the component of starch that is undigested in the small 
intestine and fermented rapidly in the colon. It is thought that the preferential fermentation of 
carbohydrate over protein, when RS is incorporated into high protein diets, leads to a 
reduction in DNA changes that might initiate CRC [4, 22]. This fermentation increases the 
production of short chain fatty acids (SCFA) [23], in particular butyrate, which is important for 
large bowel function and is the major energy source for colon epithelial cells. RS has also 
been shown to reduce production of toxic protein fermentation products [4, 24]. In vivo 
animal models demonstrate the ability of butyrate to increase the acute apoptotic response to 
a chemical carcinogen and reduce cellular proliferation to allow for repair or removal of highly 
damaged cells [25]. Studying the effect of RS in human subjects is complex due to varying 
RS sources and maintaining adequate dosing, thus it is difficult to directly pinpoint the 
protective effect RS has against CRC in humans [23, 24] [30-33]. Daily intake of fibre 
sources in the above human studies were mostly over 30g, but actual RS intake would differ 
due to varying RS content in different RS food sources. This suggests that the dose of RS 
might not have been achieved in some of these studies to have a direct effect on the colon 
and higher doses of RS should be aimed for. 
 As heme is considered to be oncogenic, either directly or indirectly, and RS has the 
capacity to reduce oncogenic DNA lesions in the colon, we investigated whether feeding 
heme (at human-relevant amounts) to mice as part of the western diet model of spontaneous 
colorectal cancer for short or long periods of time could induce pro-oncogenic adducts or 
colonic neoplasms, and if epithelial events relevant to formation of DNA lesions were 
affected. We also aimed to find out if adding RS at levels appropriate for human dietary 
intake could manipulate these parameters. 
Materials and methods 
Animals and Diets 
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 A total of 225 eight week old wild type c57bl/J male mice were obtained from the 
Animal Resource Centre, Perth, Western Australia. The Flinders University of South 
Australia Animal Welfare Committee approved all experimental procedures (ethics approval 
number 809/12). Animals were randomly placed four mice per cage and divided into dietary 
groups under controlled conditions of 22 ± 2ºC (SD), 80 ± 10% humidity and 12h light/dark 
cycle. Animals had free access to food and water and were weighed once weekly throughout 
the study period. 60 mice consumed diets for four weeks (short term) and 160 mice were on 
diets for 18 months (long term). 
 The experimental diets were based on the American Institute of Nutrition (AIN) diet 
AIN-76 with modified amounts of vitamins and minerals for rats and mice adapted from the 
western diet model of spontaneous colorectal cancer created by Newmark et al [26, 27] 
(Table 1). Our experimental diets were a modification of the AIN76 diet to give 15% total 
protein using casein (w/w) and 15% protein with 10% high amylose maize starch (HAMS). 
HAMS was supplied by the National Starch and Chemical Company, Bridgewater, NJ, and 
contains approximately 50% RS [28], therefore a total of 5% RS was added to the diet. The 
amount of heme used in this study is at a final concentration of 0.2µmol/g (supplied as hemin 
chloride, Sigma catalogue # 51280). This heme concentration resembles the heme content 
from a high red meat diet [4, 19]. Final diet preparations were placed into air sealed 
containers, stored at 4°C with fresh food in the mouse cages replaced daily. 
Faecal Analysis 
 After three weeks (short term) or six months (long term) on experimental diets fresh 
faecal samples were collected from each mouse. For measurement of faecal pH, faeces 
were placed into three times the weight-to-volume of cold saline, vortexed until emulsified 
and pH measured using a glass embodied electrode (Eutech Instruments). Another fresh 
faecal sample was placed into three times the weight-to-volume of a SCFA/phenols internal 
standard (800ml Milli Q water, 120µl heptanoic acid, 50mg of o-Cresol, pH 7.0). Duplicate 
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100µl aliquots were used to measure SCFAs (butyrate, acetate and propionate) and phenols 
and p-cresols. For SCFAs, 100μl was injected into an Agilent Technologies 6890N Network 
Gas Chromatograph System fitted with a Zebron ZB-FFAP column (0.53 mm × 30 mm) and 
measured as described previously [29]. For phenols and p-cresol, another 100μl of distillate 
was injected into a Shimadzu LC-10AD HPLC machine with RF-10AXL fluorescence detector 
set at excitation 284nm, emission 310nm and measured as described previously [30]. 
Tissue Sample collection 
 All colon samples were fixed with 10% buffered formalin solution containing 3.6% 
formaldehyde for 24 hours then transferred to 70% ethanol for processing. On completion of 
short term experimental diets 1cm of distal colon was used for analysis. After the long term 
feeding experiment the entire colon was cut longitudinally for analysis of tumours under a 
dissecting microscope before a 1cm distal colon segment was taken for analysis and all 
tumours were collected and processed for H&E staining for histological confirmation. Distal 
colonic tissue and tumours were processed through gradient alcohols and xylene, embedded 
in paraffin wax before sectioning on a microtome. 
Cell Proliferation and Apoptosis measurement 
 Proliferative activity of distal colonic epithelial cells was measured using an antibody 
specific for the nuclear proliferating antigen ki-67 (rat-anti-mouse clone TEC-3, Dako, USA) 
in combination with an immunohistochemistry detection method in paraffin embedded 
sections, as used previously [31]. Slides were visualised under light microscopy by brown 
nuclear staining and proliferation was assessed as the ki-67 positive cells per crypt column 
length. Apoptosis was measured using a terminal deoxynucleotidyl transferase dUTP nick-
end labelling (TUNEL) assay kit (Trevigen, USA) in paraffin embedded sections, following the 
manufactures instructions. Slides were visualized under light microscopy by brown nuclear 
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staining and apoptosis in the distal colon was assessed as the number of positive apoptotic 
nuclei per crypt column length. All slides were independently and randomly coded.  
DNA Adduct Quantification 
 DNA alkylation was quantified using an antibody specific for the DNA adduct O6-
Methyl-2-deoxyguanosine (O6MeG, Clone EM 2-3,Squarix Biotechnology, Germany) and the 
level of oxidative adducts was measured using an antibody specific for the DNA adduct 8-
hydroxy-2 deoxyguanosine (8-oxo, Trevigen, USA) combined with a mouse-on-mouse 
polymer horse radish peroxidase (Poly-HRP) detection system (Covance Laboratories) on 
paraffin-embedded distal colon sections. The primary antibody concentration for O6MeG was 
1:1000 (in PBS) and for 8-oxo the primary antibody was applied at 1:2000 (in PBS). 
Immunohistochemical staining procedures and computer image analysis of stained slides 
were carried out as previously described [4]. Total sum of adduct formation was calculated 
along the crypt length for each mouse and averaged for each dietary treatment. All slides 
were independently and randomly coded so that dietary groups were not known to the 
counter. 
Statistical Methods 
 Values are represented as means and standard error. Tumour outcomes are 
expressed as incidence (proportion of mice that develop neoplasia). General linear model 
univariate analysis was used to determine the main effect of RS addition and heme on all 
outcomes measured. Independent sample t-tests were performed on each variable to 
determine the difference between short term and long term feeding of each diet on DNA 
markers and cell kinetics. Colon tumours were analysed by Crosstabs Fishers Exact test. 
The null hypothesis was rejected at the 0.05 level for all statistical tests carried out using 
SPSS version 19 (IBM).  
Results 
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Body Weight and Faecal analysis 
 In the short term, no significant differences in body weight (g) were observed after 
consuming the experimental diets for four weeks although after long term feeding mice 
consuming dietary heme had significantly reduced body weights compared to mice on control 
diet (p<0.01) (Table 2). After both short and long term feeding, addition of RS to the diet 
significantly lowered faecal pH compared to those diets without RS (p<0.0001) and markedly 
increased faecal total SCFAs concentration (p<0.0001) including acetate (p<0.006), 
propionate (p<0.0001) and butyrate (p<0.0001) (Table 2). RS was also able to reduce 
concentration of faecal p-cresol (p<0.0001) and phenol (p<0.0001) in the short term (Table 
2). Heme addition had no significant effect on faecal fermentation of SCFAs, phenol or p-
cresols compared to the control after long term feeding (Table 3). Although when heme was 
combined with RS in the long term experiment there were significantly reduced 
concentrations of acetate (p<0.001), propionate (p< 0.05), butyrate (p<0.05) and total SCFAs 
(p<0.01) (Table 3) compared to the Control + RS diet. After long term feeding diets 
containing RS showed significantly reduced fermentation of phenols but not p-cresols 
compared to diets without RS (p<0.05). 
Short-term effects of heme and RS 
 In the short term, heme at 0.2µmol/g in the diet increased cell proliferation (Figure 1B) 
as measured by positive ki-67 cells in the colon compared to diets without heme (p<0.05). 
RS significantly increased crypt height in the colon compared to diets without RS (p<0.05) 
but it did not increase the proportion of ki-67-positive cells (Figure 2B and 2C). There were 
no significant effects of heme or RS on apoptotic cell counts in colonic epithelial cells (Figure 
1A and 2A). There were no significant differences after four weeks of feeding in either the 
O6MeG adduct (Figure 1D and 2D) or the 8-oxo adduct (Figure 1E and 2E) between heme 
and control diets or after the addition of RS to the diet.  
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Long-term effects of heme and RS 
 After 18 months on experimental diets, those mice fed heme showed no changes in 
proliferation, crypt height, apoptosis or DNA adduct levels compared to mice fed a heme-free 
diet (Figure 1A-1E). Diets containing RS increased colonic crypt height (p<0.01) as well as 
increasing cell proliferation (p<0.01) compared to diets without RS (Figure 2B and 2C). 
However, RS did not affect apoptosis or DNA adducts (Figure 2C, 2D and 2E). Although it 
appears heme lowered neoplasm incidence in the colon, there were no statistically significant 
differences in colon neoplasm incidence for any of the dietary interventions (Table 4). 
Diet-related changes over time 
 To ascertain if diets led to changes over time we compared short and long term 
feeding of heme and RS (Figure 3).  Dietary heme significantly lowered rates of apoptosis in 
older mice compared to their younger counterparts (Figure 3A, p<0.01). Cell proliferation 
increased and crypt height decreased with age (Figure 3B and 3C) for all dietary treatments 
(p<0.01). Diets that contained heme (p<0.01) or heme with RS (p<0.001) showed a 
significant increase in O6MeG DNA adduct accumulation over time; whereas diets without 
heme (Control and Control + RS) showed no significant difference between the two time 
points (Figure 3D). 8-oxo adducts in the colon accumulated over time (Figure 3E) with all 4 
dietary interventions (Control: p<0.05, Control + RS: p<0.001, Heme: p<0.01 and Heme + 
RS: P<0.000001). 
Discussion 
 We have identified dietary heme at a human relevant amount to increase proliferation 
in colon cells of mice in the short term, inhibit colonic apoptosis over the long term and 
contribute to accumulation of O6MeG pro-mutagenic adducts in the colon over time. 
Interestingly, these adverse changes invoked by this level of dietary heme did not increase 
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rates of colon neoplasms within the western diet model of spontaneous colorectal cancer in 
the mouse. 
 
 There is evidence that increased heme intake from red meat will catalyse the 
production of more N-nitroso Compounds (NOC) in the colonic lumen, leading to increased 
risk in developing colon cancer [20]. Heme-induced increases in NOC can lead to increased 
alkylating adducts in the colon, as NOC are potent initiators of such alkylating adducts [21]. 
We observed an accumulation of O6MeG adducts over time with heme consumption, 
however this did not accelerate colorectal oncogenesis under the conditions of the 
experiment. It may be possible that as mice age they become more susceptible to 
accumulation of DNA adducts in the presence of heme, possibly due to the cells being more 
inefficient at repairing such adducts with increasing age. Measurement of DNA repair of 
oncogenic adducts might be warranted in future studies to determine if the aging process 
effects DNA repair mechanisms and therefore accumulation of DNA lesions with 
consumption of high red meat diets. 
 Heme alone may catalyse the production of NOC’s but red meat and particularly 
processed meat [32] contain NOCs that might further contribute to alkylating DNA lesions of 
the colon. This could be one reason why heme (at the studied dose) alone did not influence 
rates of CRC. Clearly, the alkyl adducts generated were not sufficient to initiate or promote 
CRC. Whether this was due to failure to reach a sufficient number or whether it was in the 
context of a low-risk setting for CRC, given that no other mutagen was given or that there 
was no high risk factor present, we cannot be certain. This might be further explored by 
feeding higher amounts of heme but such would be above what is reasonably encountered in 
the human diet. It is likely that NOC generation in mice fed the heme diets would be minimal 
as NO and NO2 (required for NOC generation) were not added to the diet or water, and 
rodent saliva does not recycle NO2 as human saliva does [33]. Due to sampling limitations, 
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NOCs were not measured in the current study, but this would be warranted in future studies 
examining dietary heme as a cancer causing agent. It might also be that the duration of the 
current study may need to be extended beyond 18 months to see if there is further 
accumulation of O6MeGadducts and whether this increases risk for CRC. The diets we based 
our experiments on were adapted from Newmark et al [26, 27] where end-points of 18 and 
24 months saw significant increases in CRC compared to normal diets. However, due to a 
significant weight loss in heme-fed mice (table 3), as well as some early losses of mice in all 
dietary interventions resulting from the low nutritional quality of the westernised diet, 18 
months was used as the cut-off point in our study to avoid further loss of mice. 
 A high level of dietary heme has been previously shown by other researchers to 
increase cell proliferation and decrease apoptosis in the colon of rats, possibly as a result of 
increased oxidative stress and a loss of cell feedback between damaged cells and 
proliferating cells [34]. We also observed increased cell proliferative activity in the short term 
and a reduction of apoptosis over the long term in the current study, but this did not equate to 
a higher CRC risk. More recently, Ijssennagger et al [35] showed 0.2µmol of heme was 
sufficient enough to induce acute oxidative stress and delayed cytotoxic stress in the lumen 
of mice after only 2-14 days of heme consumption, with a dramatic increase in proliferating 
colon cells. In a study where heme was used at a similar concentration of 0.25µmol/g ACF 
size increased, however, there was a statistically significant reduction in number of 
azoxymethane (AOM)-induced ACFs per colon (after 100 days) compared to the control diet 
(92 ± 16 compared to 125 ± 25) [18]. There are some distinct differences with this study 
including different base diets used and the treatment with AOM to drive the CRC pathway, 
whereas we used only heme as the potential carcinogenic agent. This indicates that heme 
may increase the risk of developing CRC at higher doses but not at lower doses more 
relevant to human consumption over a longer period of time, and could explain why we saw 
no significant effect on CRC in the current study. According to two studies [17] [19] the level 
of heme-iron in cooked red meat as beef is on average 2.63mg/100g of meat. This equates 
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to an average concentration of heme in a 30% red meat diet to be 0.14µmol/g [19]. Most 
studies have used much higher doses, up to 10 times this amount of heme, ranging from 
0.25µmol/g up to 1.5µmol/g of diet [18, 34, 36], which is quite unrealistic in the context of 
human consumption. The concentration of heme in our study at 0.2µmol is very similar to 
that of the high red meat diet of 30%, representing a maximum intake of heme achieved in 
humans. Although heme may disrupt homeostasis of the cell by increasing proliferation and 
decreasing apoptosis, this had no influence on initiation or promotion of colorectal cancer. 
The effect of heme in the form of hemin on colon carcinogenesis remains questionable, with 
levels of heme present in a relatively normal diet not affecting CRC risk in the western diet 
model of spontaneous colorectal cancer.  However, more studies in other animal models 
which also include a more detailed dose evaluation are required to confirm heme’s effect on 
colorectal carcinogenesis.  
 Our findings on the effects of dietary RS support previous literature that this food 
source acts to reduce toxic protein fermentation and acts as a promoter of SCFA production, 
particularly the anti-cancer compound butyrate. There is a firm belief that the preferential 
fermentation of RS in the colon over protein leads to increased production of chemo-
protective compounds and reduction of potentially toxic compounds in the lumen [24]. 
Rodent models consistently show fermentation of RS and production of SCFAs is linked to 
decreased rates of DNA lesions in colon cells, ACFs and tumours in chemical carcinogenic 
models of colorectal cancer [22, 25, 37]. We have shown previously that RS is able to reduce 
DNA adducts induced by high red meat diets, but not high casein diets, without the use of 
chemical carcinogens, and this was related to increased SCFA and decreased protein 
fermentation [4]. The levels of heme used here did not induce detectable changes in DNA 
adducts between individual diets (both alkylating and oxidative) in the short term to detect a 
protective effect of RS despite increased SCFA production. Although Control + RS diet 
appeared to increase O6MeG adducts over time, there was a large variation between the 
mice and therefore this did not reach statistical significance. Also, over the long term, 
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addition of RS was not able to reduce the observed increase of adducts induced by heme 
and one reason for this could be the decrease in SCFA production by RS in the presence of 
heme after long periods. It is likely that the bacterial population in the colon has shifted with 
consumption of heme over longer periods, favouring a move away from beneficial bacteria 
fermentation provided by an RS diet. Previous studies have confirmed that consumption of 
dietary heme does create shifts in populations of bacteria in the colonic lumen [38]. Due to 
the small faecal sample size of the mice it was not possible to measure bacterial profile but 
this would be warranted in future studies to identify the interaction of heme with other dietary 
agents. 
 We have identified dietary heme as an agent that can increase DNA pro-mutagenic 
adducts in the colon of mice, increase cell proliferation and reduce apoptosis rates in the 
colon. We also confirm that RS can promote beneficial bacterial fermentation and reduce 
toxic protein fermentation in the colon of rodents over short periods, but SCFA production 
was not sustained over longer periods in combination with heme intake. All these changes 
observed had no influence on CRC risk when heme was studied at a human relevant amount 
with the western diet model of spontaneous colorectal cancer. The level of heme in a typical 
western diet may not be sufficient to initiate or promote CRC alone. This suggests that heme 
may act with other components of red and processed meat, such as NOCs, contributing to 
DNA damaging events in the colon that might lead to colorectal carcinogenesis. 
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Table 1: Composition of Experimental Diets in g/100g 
Ingredient Control Control + RS Heme Heme + RS 
Casein 17.6 17.6 17.6 17.6 
Corn starch 10 - 10 - 
Hi-Maize™ - 10 - 10 
Sucrose 45.48 45.48 45.48 45.48 
Sunflower Seed oil† 16.8 16.8 16.8 16.8 
Lard 3.2 3.2 3.2 3.2 
α-cellulose 2 2 2 2 
L-cysteine 0.3 0.3 0.3 0.3 
Choline 0.12 0.12 0.12 0.12 
Minerals* 3.5 3.5 3.5 3.5 
Vitamins* 1 1 1 1 
DL-Methionine 0.15 0.15 0.15 0.15 
Hemin# - - 0.01304 0.01304 
* AIN-76 vitamin and mineral mixtures with modified calcium at 0.5 mg/g, phosphorus at 3.6 
mg/g, folic acid at 0.23 mg/g, and vitamin D3 at 0.11 IU/g. 
† Sunflower seed oil contained no added antioxidants. 
# Hemin is at 0.2µmol/g of total diet. 
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Table 2: Short Term Study Measures of Body Weight and Fermentation1 
Variable Unit 
Experimental Diet Groups 
Control (n=12) 
Control + RS 
(n=12) 
Heme (n=12) 
Heme + RS 
(n=12) 
Body 
Weight 
g 28.5 ± 0.4 28.4 ± 0.5 29.3 ± 0.9 28.6 ± 0.5 
Fecal pH - 7.8 ± 0.2 7.1 ± 0.2a 7.6 ± 0.1 7.0 ± 0.1a 
Total 
SCFAs 
µmol/g 45.6 ±11.3 109.9 ± 10.4a 55.6 ± 12.2 117.3 ± 16.9a 
Butyrate µmol/g 1.8 ± 0.8 19.2 ± 3.2a 4.9 ± 0.9 20.4 ± 3.1a 
Acetate µmol/g 36.1 ± 8.7 61.2 ± 6.6a 42.0 ± 9.8 68.1 ± 10.3a 
Propionate µmol/g 7.6 ± 1.9 29.6 ± 2.5a 8.7 ± 1.8 28.8 ± 4.1a 
Phenol µg/g 7.2 ± 1.6 0.8 ± 0.6a 7.3 ± 1.7 0.2 ± 0.1a 
p-cresol µg/g 21.7 ± 2.5 11.8 ± 1.6a 21.5 ± 3.3 9.3 ± 1.1a 
1 Data represented as Mean ± SE 
a  Control + RS and Heme + RS is significantly different to Control and Heme 
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Table 3: Long Term Study Measures of Body Weight and Fermentation1 
Variable Unit 
Experimental Diet Groups 
Control (n=40) 
Control + RS 
(n=40) 
Heme (n=40) 
Heme + RS 
(n=40) 
Body 
Weight 
g 58.3 ± 2.1 52.6 ± 1.8 48.0 ± 2.1a 51.7 ± 1.4 
Fecal pH - 7.7 ± 0.2 7.1 ± 0.2a 7.5 ± 0.1d 6.9 ± 0.1a,c 
Total SCFAs µmol/g 25.3 ± 3.8b 52.4 ± 5.1a 22.3 ± 3.1b 19.0 ± 2.6b 
Butyrate µmol/g 4.9  ±1.5b 18.8 ± 1.9a 6.8 ± 1.3b 6.2 ± 0.7b 
Acetate µmol/g 17.7 ± 2.8 15.1 ± 1.6 8.4 ± 1.0a 7.1 ± 1.3a,b 
Propionate µmol/g 2.8 ± 0.3b 14.8 ± 1.6a 4.5 ± 0.7b 3.5 ± 0.5b 
Phenol µg/g 2.0 ± 0.7 0.9 ± 0.1 1.8 ± 0.2 1.2 ± 0.4 
p-cresol µg/g 7.5 ± 2.1 11.1 ± 1.7 7.8 ± 0.7 6.7 ± 1.1 
1 Data represented as Mean ± SE 
a significantly different to Control 
b significantly different to Control + RS 
c significantly different to Heme  
d significantly different to Heme + RS 
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Table 4: Main effects of Dietary Interventions on Colon Neoplasm Incidence 
Heme Effect Incidence (%) RS Effect Incidence (%) 
No Heme 4.45 No RS 3.35 
Heme 0 RS 1.1 
p value* 0.134 p value* 0.523 
* Cross tabulation performed for colon cancer using Fishers exact test. 
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Figure Legends 
 
Figure 1: Effect of dietary heme on apoptosis (A), cell proliferation (B), colonic crypt height 
(C), O6MeG adduct (D) and 8-oxo adduct (E) load in the distal colon after short term and long 
term experiments. Diets without heme represented by grey bars, diets with heme 
represented by black bars. Data are represented as means ± SE. **p<0.01 
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Figure 2: Effect of dietary RS on apoptosis (A), cell proliferation (B), colonic crypt height (C), 
O6MeG adduct (D) and 8-oxo adduct (E) in the distal colon after short term and long term 
experiments. Diets without RS represented as white bars, diets with RS represented as grey 
bars. Data are represented as means ± SE. *p<0.05, **p<0.01 
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Figure 3: Changes in the distal colon over time from 4 weeks (white bars) to 18 months 
(grey bars) for apoptosis (A), cell proliferation (B), colonic crypt height (C) O6MeG adduct (D) 
and 8-oxo adduct (E). Data are represented by means ± SE. *p<0.05, **p<0.01, ***p<0.001, 
****p<0.000001, *****p<0.000001 
 
 
 
